X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (14) 14
oncology (13) 13
female (9) 9
adult (7) 7
aged (6) 6
cancer (6) 6
middle aged (6) 6
ovarian cancer (6) 6
chemotherapy (5) 5
genes, brca1 (5) 5
article (4) 4
breast neoplasms - genetics (4) 4
ovarian neoplasms - genetics (4) 4
retrospective studies (4) 4
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
brca1 (3) 3
carcinoma (3) 3
cisplatin (3) 3
disease-free survival (3) 3
genes, brca2 (3) 3
mutation (3) 3
ovarian neoplasms - drug therapy (3) 3
ovarian neoplasms - pathology (3) 3
ovarian-cancer (3) 3
paclitaxel (3) 3
treatment outcome (3) 3
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
base sequence (2) 2
bevacizumab (2) 2
braf (2) 2
breast neoplasms - metabolism (2) 2
ca-125 antigen - metabolism (2) 2
ca125 (2) 2
care and treatment (2) 2
carriers (2) 2
cell line, tumor (2) 2
comparative genomic hybridization (2) 2
deletions (2) 2
endocrine system diseases (2) 2
erk (2) 2
fdg-pet/ct (2) 2
female genital diseases and pregnancy complications (2) 2
gene (2) 2
genetic predisposition to disease (2) 2
genetics & heredity (2) 2
hematology, oncology and palliative medicine (2) 2
identification (2) 2
lines (2) 2
male (2) 2
melanoma (2) 2
melanoma - genetics (2) 2
melanoma - metabolism (2) 2
metastasis (2) 2
molecular sequence data (2) 2
neoplasm staging (2) 2
oncology, experimental (2) 2
ovarian neoplasms - complications (2) 2
paclitaxel - administration & dosage (2) 2
paclitaxel - adverse effects (2) 2
pharmacokinetics (2) 2
point mutation (2) 2
proto-oncogene proteins b-raf - antagonists & inhibitors (2) 2
proto-oncogene proteins b-raf - genetics (2) 2
recurrence (2) 2
research (2) 2
risk (2) 2
skin and connective tissue diseases (2) 2
sorafenib (2) 2
trial (2) 2
urologic and male genital diseases (2) 2
1st-line treatment (1) 1
activation (1) 1
adhesion (1) 1
adjuvant temozolomide (1) 1
amino acid substitution (1) 1
amino acid substitution - drug effects (1) 1
angiogenesis (1) 1
angiogenesis inhibitors (1) 1
animals (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic agents, phytogenic - adverse effects (1) 1
antineoplastic agents, phytogenic - pharmacokinetics (1) 1
antineoplastic agents, phytogenic - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
apoptosis - physiology (1) 1
apoptosis regulatory proteins - antagonists & inhibitors (1) 1
apoptosis regulatory proteins - biosynthesis (1) 1
apoptosis regulatory proteins - genetics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 7, pp. 2750 - 2760
This study addresses the role of PTEN loss in intrinsic resistance to the BRAF inhibitor PLX4720. Immunohistochemical staining of a tissue array covering all... 
METASTATIC MELANOMA | APOPTOSIS | PROTEIN | ONCOLOGY | PHOSPHORYLATION | CUTANEOUS MELANOMA | RAF KINASE | CANCER | MEDIATES RESISTANCE | LINES | ERK | RNA, Small Interfering - genetics | Up-Regulation | Humans | Drug Resistance, Neoplasm | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Proto-Oncogene Proteins - biosynthesis | Bcl-2-Like Protein 11 | Melanoma - genetics | Apoptosis Regulatory Proteins - genetics | Indoles - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Apoptosis Regulatory Proteins - biosynthesis | Melanoma - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | PTEN Phosphohydrolase - deficiency | Membrane Proteins - genetics | PTEN Phosphohydrolase - biosynthesis | Proto-Oncogene Proteins - genetics | Melanoma - pathology | Sulfonamides - pharmacology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Membrane Proteins - biosynthesis | Membrane Proteins - antagonists & inhibitors | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Apoptosis Regulatory Proteins - antagonists & inhibitors | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Apoptosis - physiology | Mutation | RNA, Small Interfering - administration & dosage | Index Medicus | PTEN | melanoma | BRAF | PLX4032 | therapy | resistance
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 05/2003, Volume 12, Issue 9, pp. 1055 - 1061
The recent identification of major genomic rearrangements in breast and breast/ovarian cancer families has widened the mutational spectrum of the BRCA1 gene,... 
RECOMBINATION | VARIANTS | GENE REARRANGEMENTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | SEQUENCE | GENETICS & HEREDITY | KB DELETION | OVARIAN-CANCER | FRENCH BREAST | IDENTIFICATION | PCR | COMBED DNA | Ovarian Neoplasms - genetics | Breast Neoplasms - genetics | Recombination, Genetic | Humans | Female | Italy | Male | Genes, BRCA1 | Index Medicus
Journal Article
Journal of the Turkish German Gynecology Association, ISSN 1309-0399, 09/2015, Volume 16, Issue 3, pp. 137 - 144
We evaluated the efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in recurrent disease, response to therapy,... 
FDG-PET/CT | CA125 | Overall survival | Disease-free survival | Ovarian cancer
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2012, Volume 69, Issue 3, pp. 781 - 787
Malignant pleural effusion (MPE) is a frequent complication in many types of tumors diminishing the patient’s ability to perform activities. Despite various... 
Chemotherapy | Medicine & Public Health | Paclitaxel | Cancer Research | Oncology | Breast cancer | Pharmacology/Toxicology | Malignant pleural effusion | Ovarian cancer | CELL LUNG-CANCER | TRIAL | DIAGNOSIS | MANAGEMENT | CISPLATIN | ONCOLOGY | PHARMACOLOGY & PHARMACY | Instillation, Drug | Humans | Middle Aged | Pleural Cavity - metabolism | Ovarian Neoplasms - pathology | Paclitaxel - pharmacokinetics | Ovarian Neoplasms - complications | Pleural Effusion, Malignant - pathology | Breast Neoplasms - metabolism | Pleural Effusion, Malignant - drug therapy | Dose-Response Relationship, Drug | Tissue Distribution | Antineoplastic Agents, Phytogenic - administration & dosage | Adult | Female | Ovarian Neoplasms - metabolism | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Ovarian Neoplasms - drug therapy | Antineoplastic Agents, Phytogenic - adverse effects | Pleural Effusion, Malignant - metabolism | Paclitaxel - adverse effects | Breast Neoplasms - drug therapy | Paclitaxel - therapeutic use | Drainage | Breast Neoplasms - complications | Disease-Free Survival | Breast Neoplasms - pathology | Aged | Antimitotic agents | Pleural effusions | Care and treatment | Oncology, Experimental | Research | Antineoplastic agents | Cancer | Tumors | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 09/2009, Volume 69, Issue 17, pp. 7030 - 7037
Journal Article
Journal Article
Tumori, ISSN 0300-8916, 11/2010, Volume 96, Issue 6, pp. 918 - 925
Journal Article
Journal Article
Research and Reports in Urology, ISSN 2253-2447, 05/2011, Volume 3, pp. 69 - 82
Renal cell carcinoma (RCC) is a common malignancy worldwide with approximately 95,000 new cases per year and ranks as the sixth cause of cancer deaths. Until... 
Kidney cancer
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 2012, Volume 30, Issue 3, pp. 240 - 246
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2011, Volume 83, Issue 1, pp. 84 - 98
Journal Article
Open Access Journal of Urology, ISSN 1179-1551, 2011, Volume 3, Issue 1, pp. 69 - 82
Renal cell carcinoma (RCC) is a common malignancy worldwide with approximately 95,000 new cases per year and ranks as the sixth cause of cancer deaths. Until... 
Pharmacokinetics | Angiogenesis | Sorafenib
Journal Article
Open Access Journal of Urology, ISSN 1179-1551, 05/2011, Volume 2011, Issue default, pp. 69 - 82
Fable Zustovich1, Giuseppe Lombardi1, Davide Pastorelli1, Patrizia Farina1, Massimo Dal Bianco2, Luca De Zorzi2, Maurizia Dalla Palma1, Ornella Nicoletto1,... 
Journal Article